NOSTRAND ROBERT L VAN Insider Trading
Get free email notifications about insider trading for NOSTRAND ROBERT L VAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of NOSTRAND ROBERT L VAN. NOSTRAND ROBERT L VAN is a VP, & Chief Financial Officer in OSI PHARMACEUTICALS INC ($OSIP) and a Director in METABOLIX, INC. ($MBLX) and a in ACHILLION PHARMACEUTICALS INC ($ACHN) and a Director in ACHILLION PHARMACEUTICALS INC ($ACHN) and a Director in SELLAS Life Sciences Group, Inc. ($GALE) and a Director in Enumeral Biomedical Holdings, Inc. ($ENUM) and a Director in Intra-Cellular Therapies, Inc. ($ITCI).
Address: C/O OSI PHARMACEUTICALS, INC. 58 SOUTH SERVICE ROAD, SUITE 110 MELVILLE 11747 NY
Companies in which NOSTRAND ROBERT L VAN is an Insider
ACHILLION PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of NOSTRAND ROBERT L VAN:
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 29 2020
$ACHN Market Capitalization: $579.52M
$ACHN Previous Close: $4.38
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Enumeral Biomedical Holdings, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of NOSTRAND ROBERT L VAN: Director
Holdings: 268,121 shares
Current Value: $42,899
Latest Transaction: Jan 05 2017
$ENUM Market Capitalization: $8.33M
$ENUM Previous Close: $0.16
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Intra-Cellular Therapies, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of NOSTRAND ROBERT L VAN: Director
Holdings: 8,273 shares
Current Value: $120,289
Latest Transaction: Apr 02 2021
$ITCI Market Capitalization: $607.92M
$ITCI Previous Close: $14.54
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
OSI PHARMACEUTICALS INC
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of NOSTRAND ROBERT L VAN: VP, & Chief Financial Officer
Holdings: 4,899 shares
Latest Transaction: May 03 2005
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SELLAS Life Sciences Group, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of NOSTRAND ROBERT L VAN: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 08 2021
$SLS Market Capitalization: $9.04M
$SLS Previous Close: $1.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
YIELD10 BIOSCIENCE, INC.
Industry: MISCELLANEOUS PLASTIC PRODUCTS [3080]
Position of NOSTRAND ROBERT L VAN: Director
Holdings: 11,293 shares
Latest Transaction: May 26 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of NOSTRAND ROBERT L VAN
Sentiment: All, ACHN, ENUM, ITCI, OSIP, SLS, MBLX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 26 2021 | MBLX | YIELD10 BIOSCIENCE ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | A | 7.96 | 5,000 | 39,800 | 5,000 | |
| Apr 02 2021 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Grant | A | 33.93 | 208 | 7,057 | 8,273 | 8.1 K to 8.3 K (+2.58 %) |
| Apr 02 2021 | MBLX | YIELD10 BIOSCIENCE ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | A | 12.54 | 383 | 4,803 | 383 | |
| Mar 08 2021 | SLS | SELLAS Life Scienc ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | A | 8.00 | 7,500 | 60,000 | 7,500 | |
| Jan 04 2021 | MBLX | YIELD10 BIOSCIENCE ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | A | 5.78 | 818 | 4,728 | 818 | |
| Jul 02 2020 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Grant | A | 25.67 | 275 | 7,059 | 7,567 | 7.3 K to 7.6 K (+3.77 %) |
| Jul 02 2020 | MBLX | YIELD10 BIOSCIENCE ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | A | 6.26 | 777 | 4,864 | 777 |